National Medicinal Drugs Policy

Last updated June 18, 2023

The National Medicinal Drugs Policy is an essential part of Sri Lanka's Health Policy, aimed at the rational use of pharmaceuticals.

By the beginning of the 21st Century, Sri Lanka had approximately 9,000 registered medicinal drugs, hundreds of which were non-essential, unnecessary, highly expensive or even dangerous. In 1996 the Government of President Chandrika Kumaratunga had established a new health policy, one stated aim of which was to develop and implement a National Drug Policy for the rational use and distribution of drugs. While this policy continues to this day, no concrete measures had been adopted for its implementation.

In 2005 the United People's Freedom Alliance Government promised to establish a National Medicinal Drugs Policy (NMPD) that would enable Sri Lankans significantly to cut down on drug expenses and get quality drugs at affordable prices while saving billions of Rupees in foreign exchange for the country. It anticipated that the implementation of the NMDP could reduce the number of drugs imported, prescribed and sold in Sri Lanka to about 350 varieties.

Consultations were held with all stakeholders, presided over by Prof. Krisantha Weerasuriya, the World Health Organization (WHO) Regional Advisor, Essential Medicines over four days in June 2005, and the draft for the NMDP was prepared. In October, the Minister of Health obtained cabinet approval for the draft NMDP and promised that the appropriate legislation would be introduced in parliament.

In February 2006 the Health Ministry called another meeting of all stakeholders and the Minister gave assurances that the NMDP would be implemented within weeks. An eighteen-member National Standing Committee (NSC), including a representative of the People's Movement for the Rights of Patients, was appointed in March to oversee and expedite the implementation of the Drug Policy based on the Seneka Bibile principles of rational drug use. The NSC was advised by the Legal Draftsman that new legislation should be drafted for the establishment of the NMDA.

During 2007, popular pressure for the implementation of the NMPD grew. In October, the Cabinet approved to a Memorandum submitted by Healthcare and Nutrition Minister Nimal Siripala de Silva on the establishment of the National Medicinal Drug Authority (NMDA) and granted its approval to draft a new Act with the assistance of the Legal Draftsman to expedite the implementation of the NMPD by repealing or amending the existing Cosmetics Devices and Drugs Act where necessary.

Although the scene was created to establish the Authority, it did not take place due to the civil war in the North of the country. The stalemate of Drugs being regulated by the Ministry bureaucrats continued.

From 2010 to late 2014, Mr Maithripala Sirisena was the Minister of Health and strongly supported the establishment of the Authority but there was no support from the President, Mr Mahinda Rajapakse. At the end of 2014, Mr Sirisena challenged Mr Rajapaksa at the Presidential Elections and won. Implementing the National Medicines Policy and within it the National Medicines Regulatory Authority was a part of the 100 day plan of President Sirisena. The Act to establish the Authority was finally passed in early 2015.

Finally in mid 2015, an independent Medicines Regulatory Authority was established in Sri Lanka.

There is an interesting discussion on regulating Medicines Prices by the NMRA (July 2020) in e-drug. This does show it is possible to regulate prices of medicines and the industry/trade despite protesting will remain in the market as they can get a reasonable Return on the Investment.

Related Research Articles

The United States Food and Drug Administration is a federal agency of the Department of Health and Human Services. The FDA is responsible for protecting and promoting public health through the control and supervision of food safety, tobacco products, caffeine products, dietary supplements, prescription and over-the-counter pharmaceutical drugs (medications), vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices (ERED), cosmetics, animal foods & feed and veterinary products.

<span class="mw-page-title-main">Medication</span> Substance used to diagnose, cure, treat, or prevent disease

A medication is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and relies on the science of pharmacology for continual advancement and on pharmacy for appropriate management.

<span class="mw-page-title-main">Regulation of therapeutic goods</span> Legal management of drugs and restricted substances

The regulation of therapeutic goods, defined as drugs and therapeutic devices, varies by jurisdiction. In some countries, such as the United States, they are regulated at the national level by a single agency. In other jurisdictions they are regulated at the state level, or at both state and national levels by various bodies, as in Australia.

The European Medicines Agency (EMA) is an agency of the European Union (EU) in charge of the evaluation and supervision of pharmaceutical products. Prior to 2004, it was known as the European Agency for the Evaluation of Medicinal Products or European Medicines Evaluation Agency (EMEA).

The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is an initiative that brings together regulatory authorities and pharmaceutical industry to discuss scientific and technical aspects of pharmaceutical product development and registration. The mission of the ICH is to promote public health by achieving greater harmonisation through the development of technical Guidelines and requirements for pharmaceutical product registration.

The National Medical Products Administration was founded on the basis of the former State Food and Drug Administration (SFDA). In March 2013, the former regulatory body was rebranded and restructured as the China Food and Drug Administration, elevating it to a ministerial-level agency. In 2018, as part of China's 2018 government administration overhaul, the name was changed to 'National Medical Products Administration' and merged into the newly created State Administration for Market Regulation. The headquarters are in Xicheng District, Beijing.

Senaka Bibile was a Sri Lankan pharmacologist. He was the founder of Sri Lanka's drug policy, which was used as a model for development of policies based on rational pharmaceutical use in other countries as well by the World Health Organization, the United Nations Conference on Trade and Development (UNCTAD) and the Non-Aligned Movement. Due to the far reaching effects of his proposals and policies, he has been called the 'greatest medical benefactor of humanity that Sri Lanka has hitherto produced'.

An essential medicines policy is one that aims at ensuring that people get good quality drugs at the lowest possible price, and that doctors prescribe the minimum of required drugs in order to treat the patient's illness. The pioneers in this field were Sri Lanka and Chile.

The Sri Lanka National Pharmaceuticals Policy was established in the 1970s following the submission of a report by Dr S.A. Wickremasinghe and Prof. Seneka Bibile. It aimed at ensuring that people get good quality drugs at the lowest possible price and that doctors would prescribe the minimum required drugs to treat the patient's illness. It was a pioneer in the field of rational National pharmaceuticals policy.

The State Pharmaceuticals Corporation (SPC) is a state-owned enterprise with its headquarters in Colombo, Sri Lanka. It is the largest supplier of drugs in the country, and is tasked with providing quality-assured health care items that are safe and effective, at an affordable price, while educating the public on the rational use of drugs. It employees about 600 staff.

The pharmaceutical industry in Bangladesh is one of the most developed technology sectors within the country. Manufacturers produce insulin, hormones, and cancer drugs. This sector provides 97% of the total medicinal requirement of the local market. The industry also exports medicines to global markets, including Europe. Pharmaceutical companies are expanding their business with the aim to expand the export market.

Many developing nations have developed national drug policies, a concept that has been actively promoted by the WHO. For example, the national drug policy for Indonesia drawn up in 1983 had the following objectives:

Pharmacy in China involves the activities engaged in the preparation, standardization and dispensing of drugs, and its scope includes the cultivation of plants that are used as drugs, the synthesis of chemical compounds of medicinal value, and the analysis of medicinal agents. Pharmacists in China are responsible for the preparation of the dosage forms of drugs, such as tablets, capsules, and sterile solutions for injection. They compound physicians', dentists', and veterinarians' prescriptions for drugs. Pharmacological activities are also closely related to pharmacy in China.

The National Security Council (NSC) of Sri Lanka is the executive body of the Sri Lankan government that is charged with the maintenance of national security with authority to direct the Sri Lankan military and Police.

Maithripala Yapa Sirisena is a Sri Lankan politician who served as the seventh President of Sri Lanka from 9 January 2015 to 18 November 2019. Sirisena is Sri Lanka's first president from the North Central Province of the country and does not belong to the traditional Sri Lankan political elite. He is currently a member of parliament from Polonnaruwa.

Faculty of Allied Health Sciences, University of Peradeniya is one of the nine faculties of University of Peradeniya and started in 2007. Faculty of Allied Health Sciences (FAHS) was inaugurated on 16 January 2007. As the faculty offers professional degree programmes, students are introduced to basic concepts in medical sciences followed by mandatory hospital based training. All degree programmes consist of 120 credits curricula which have been designed in par with International standards. Several departments have established active foreign collaborations in teaching and research. This is the very first faculty of Allied Health Sciences in Sri Lanka..

The Pharmacy and Poisons Board is the Drug Regulatory Authority established under the Pharmacy and Poisons Act, Chapter 244 of the Laws of Kenya.

The National Pharmaceutical Pricing Authority (NPPA) is a government regulatory agency that controls the prices of pharmaceutical drugs in India. National Pharmaceutical Pricing Authority (NPPA) was constituted vide Government of India Resolution dated 29th August 1997 as an attached office of the Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers as an independent Regulator for pricing of drugs and to ensure availability and accessibility of medicines at affordable prices.

Thisuri Wanniarachchi is a Sri Lankan author and public policy specialist. She is known for her books Colombo Streets, which won a 2009 State Literary Award, and The Terrorist's Daughter (2014) She is also known for her stint as President Maithripala Sirisena's Assistant Director of Sustainable Development and the National Coordinator of the "Vision 2030" Sustainable Development Policy Formulation Project. and her work for the World Bank. Wanniarachchi resigned from her position in the Sirisena Administration in the immediate aftermath of the unconstitutional coup of October 2018. She later served as the Secretary to the President's Expert Committee to Restructure SriLankan Airlines. Wanniarachchi also served as the Lead Analyst of the Ministry of Economic Reforms in the Government of Sri Lanka in 2019.

External reference pricing (ERP), also known as international reference pricing, is the practice of regulating the price of a medication in one country, by comparing with the price in a "basket" of other reference countries. It contrasts with internal reference pricing, where the price of one drug is compared to the domestic price of therapeutically related drugs, and with cost-plus pricing, where the price involves negotiating an acceptable markup to the unit cost to develop and produce.

References

External links

Please see the links to the National Medicinal Drug Policy adopted by the government of Sri Lanka:

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.